Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Classement en actions #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Prix de l'action
$0.5099
Dernière synchronisation: 2024-10-15
Capitalisation boursière
$7.60M
Changement (1 jour)
2.02%
Changement (1 an)
0.00%
Pays
US
Échange Anew Medical, Inc. (WENA)

Catégorie

EPS pour Anew Medical, Inc. (WENA)
EPS au June 2024 TTM : $0.00
Selon les derniers rapports financiers et le cours de l'action de Anew Medical, Inc., l’EPS actuel de la société (TTM) est de $0.00. À la fin de 2022, la société avait un EPS de $0.08 une augmentation par rapport à celui de 2021, qui était de $-0.09.
Historique de l'EPS de Anew Medical, Inc. de 2021 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) 0.00 -102.64%
2023 $0.14 69.29%
2022 $0.08 -196.73%
2021 $-0.09 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -468,208.11%
US
$27.74 -749,829.73%
NL
- -
CH
- -
KR
$13.70 -370,372.97%
BE